Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous excess doppler ultrasound: What radiologists should know in 2026.

World journal of radiology·2026
Same author

Fluid Tolerance in Acute Kidney Injury: Is Point-of-Care Ultrasound the Future of Hemodynamic Assessment?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

VExUS in Mechanical Circulatory Support: Unveiling the Role of Doppler Ultrasound in Assessing Venous Congestion.

POCUS journal·2026
Same author

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease.

World journal of nephrology·2026
Same author

Advances in Cardiorenal Medicine: The Year 2025 in Review.

Cardiorenal medicine·2026
Same author

The Competency Gap in Point-of-Care Ultrasound: Premature Expertise Undermines the Promise of Ultrasound in Nephrology.

Kidney360·2026

Related Experiment Video

Updated: Jun 10, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Hepato-Cardio-Renal Interactions and Transplant Implications.

Abhilash Koratala1,2, Amir Kazory3

  • 1Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI.

Transplantation
|June 9, 2026
PubMed
Summary

Acute kidney injury in cirrhosis, known as hepatorenal syndrome (HRS), is a complex multisystem issue. Emerging evidence supports a hepato-cardio-renal syndrome framework, linking liver, heart, and kidney dysfunction.

More Related Videos

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Related Experiment Videos

Last Updated: Jun 10, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Area of Science:

  • Hepatology
  • Nephrology
  • Cardiology
  • Critical Care Medicine

Background:

  • Acute kidney injury (AKI) is a significant complication in cirrhosis.
  • Hepatorenal syndrome (HRS) is the most severe manifestation of AKI in cirrhosis.
  • HRS is increasingly viewed as a multisystem circulatory disturbance, not just a functional renal disorder.

Purpose of the Study:

  • To synthesize mechanistic insights into the hepato-cardio-renal syndrome in cirrhosis.
  • To emphasize the roles of circulatory derangements, cirrhotic cardiomyopathy, congestive nephropathy, and inflammation.
  • To discuss evolving diagnostic and therapeutic strategies for AKI in advanced liver disease.

Main Methods:

  • Literature synthesis of mechanistic insights.
  • Review of diagnostic paradigms, including point-of-care ultrasonography.
  • Analysis of therapeutic implications and impact on liver transplantation.

Main Results:

  • Growing evidence supports a unified hepato-cardio-renal syndrome framework.
  • Impaired cardiac reserve, hemodynamic derangements, and inflammation are key contributors to renal dysfunction.
  • Point-of-care ultrasonography offers advanced hemodynamic phenotyping.

Conclusions:

  • The hepato-cardio-renal syndrome framework provides a comprehensive understanding of AKI in cirrhosis.
  • Evolving diagnostic and therapeutic approaches are crucial for managing these complex patients.
  • This syndrome impacts liver transplant evaluation and management significantly.